Orthocell Ltd (ASX:OCC) has appointed Device Technologies Ltd (DVT) as exclusive distributor of Remplir™ for peripheral nerve repair across Australia and New Zealand.
DVT has established relationships with leading plastic reconstructive and orthopaedic surgeons and an experienced sales team throughout both countries.
Looking ahead, Orthocell is now well-positioned to gain commercial traction with this product in Australia and to expand into the US, the largest global healthcare market in the world.
“Innovative medical solutions”
Orthocell managing director Paul Anderson said: “Device Technologies is a leading supplier of innovative medical solutions to hospitals and healthcare professionals throughout Australia and New Zealand.
“We are delighted to be working with Device Technologies, with their specialist capabilities and resources, to lead the marketing, promotion and distribution of Remplir.
“Device Technologies has established relationships with plastic surgeons and orthopaedic specialists and a successful track record in driving the market entry of high-quality products.”
Agreement summary
DVT will market and distribute Remplir™ for use in the surgical repair of peripheral nerves across Australia and New Zealand, undertaking targeted promotion activities, initiating sales, as well as expanding the network of referring plastic and orthopaedic surgeons.
The exclusive distribution agreement has an initial term of five years and enables Orthocell access to this strategic market, with a growing uptake of Australian Made, high-quality healthcare products.
Device Technologies CEO Mick Trevaskis said: “I am extremely excited to partner with Orthocell to bring their Australian Made range of peripheral nerve repair membranes to plastic and orthopaedic surgeons around Australia and New Zealand.
“At Device Technologies, we believe in investing in innovative technologies as part of a holistic portfolio that provides value to our customers and benefits their patients.
“We look forward to working with the team at Orthocell to improve patient outcomes across the plastic reconstructive and orthopaedic industry.”
About DVT
Since 1992, Device Technologies is providing healthcare professionals with access to innovative, high-quality medical devices and solutions from around the world.
The company’s vision is to enable superior health outcomes by connecting healthcare professionals with the finest medical technologies and supplies in the market.
DVT continues to grow, with over 200 trusted brands and 1000 highly skilled staff across Australia, New Zealand and Asia.
About Remplir™
Remplir™ is manufactured by Orthocell at its GMP (Good Manufacturing Practice) facility in WA, using the company’s proprietary SMRT™ manufacturing technology.
This technology was developed in conjunction with Professor Minghao Zheng, The University of Western Australia and the Perron Institute.